Global Peptide Hormone Sales Market Report 2016

Publisher Name :
Date: 13-Oct-2016
No. of pages: 125
Inquire Before Buying

Notes:

Sales, means the sales volume of Peptide Hormone

Revenue, means the sales value of Peptide Hormone

This report studies sales (consumption) of Peptide Hormone in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Pfizer

- Roche

- Sanofi

- Merck

- Eli Lilly

- Novo Nordisk

- Boehringer Ingelheim

- Par Pharma

- BioPartners

- Innovate

- Tarix Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Peptide Hormone in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Peptide Hormone in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Peptide Hormone Sales Market Report 2016

Table of Contents
Global Peptide Hormone Sales Market Report 2016
1 Peptide Hormone Overview
1.1 Product Overview and Scope of Peptide Hormone
1.2 Classification of Peptide Hormone
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Peptide Hormone
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Peptide Hormone Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Peptide Hormone (2011-2021)
1.5.1 Global Peptide Hormone Sales and Growth Rate (2011-2021)
1.5.2 Global Peptide Hormone Revenue and Growth Rate (2011-2021)
2 Global Peptide Hormone Competition by Manufacturers, Type and Application
2.1 Global Peptide Hormone Market Competition by Manufacturers
2.1.1 Global Peptide Hormone Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Peptide Hormone Revenue and Share by Manufacturers (2011-2016)
2.2 Global Peptide Hormone (Volume and Value) by Type
2.2.1 Global Peptide Hormone Sales and Market Share by Type (2011-2016)
2.2.2 Global Peptide Hormone Revenue and Market Share by Type (2011-2016)
2.3 Global Peptide Hormone (Volume and Value) by Regions
2.3.1 Global Peptide Hormone Sales and Market Share by Regions (2011-2016)
2.3.2 Global Peptide Hormone Revenue and Market Share by Regions (2011-2016)
2.4 Global Peptide Hormone (Volume) by Application
3 USA Peptide Hormone (Volume, Value and Sales Price)
3.1 USA Peptide Hormone Sales and Value (2011-2016)
3.1.1 USA Peptide Hormone Sales and Growth Rate (2011-2016)
3.1.2 USA Peptide Hormone Revenue and Growth Rate (2011-2016)
3.1.3 USA Peptide Hormone Sales Price Trend (2011-2016)
3.2 USA Peptide Hormone Sales and Market Share by Manufacturers
3.3 USA Peptide Hormone Sales and Market Share by Type
3.4 USA Peptide Hormone Sales and Market Share by Application
4 China Peptide Hormone (Volume, Value and Sales Price)
4.1 China Peptide Hormone Sales and Value (2011-2016)
4.1.1 China Peptide Hormone Sales and Growth Rate (2011-2016)
4.1.2 China Peptide Hormone Revenue and Growth Rate (2011-2016)
4.1.3 China Peptide Hormone Sales Price Trend (2011-2016)
4.2 China Peptide Hormone Sales and Market Share by Manufacturers
4.3 China Peptide Hormone Sales and Market Share by Type
4.4 China Peptide Hormone Sales and Market Share by Application
5 Europe Peptide Hormone (Volume, Value and Sales Price)
5.1 Europe Peptide Hormone Sales and Value (2011-2016)
5.1.1 Europe Peptide Hormone Sales and Growth Rate (2011-2016)
5.1.2 Europe Peptide Hormone Revenue and Growth Rate (2011-2016)
5.1.3 Europe Peptide Hormone Sales Price Trend (2011-2016)
5.2 Europe Peptide Hormone Sales and Market Share by Manufacturers
5.3 Europe Peptide Hormone Sales and Market Share by Type
5.4 Europe Peptide Hormone Sales and Market Share by Application
6 Japan Peptide Hormone (Volume, Value and Sales Price)
6.1 Japan Peptide Hormone Sales and Value (2011-2016)
6.1.1 Japan Peptide Hormone Sales and Growth Rate (2011-2016)
6.1.2 Japan Peptide Hormone Revenue and Growth Rate (2011-2016)
6.1.3 Japan Peptide Hormone Sales Price Trend (2011-2016)
6.2 Japan Peptide Hormone Sales and Market Share by Manufacturers
6.3 Japan Peptide Hormone Sales and Market Share by Type
6.4 Japan Peptide Hormone Sales and Market Share by Application
7 India Peptide Hormone (Volume, Value and Sales Price)
7.1 India Peptide Hormone Sales and Value (2011-2016)
7.1.1 India Peptide Hormone Sales and Growth Rate (2011-2016)
7.1.2 India Peptide Hormone Revenue and Growth Rate (2011-2016)
7.1.3 India Peptide Hormone Sales Price Trend (2011-2016)
7.2 India Peptide Hormone Sales and Market Share by Manufacturers
7.3 India Peptide Hormone Sales and Market Share by Type
7.4 India Peptide Hormone Sales and Market Share by Application
8 Southeast Asia Peptide Hormone (Volume, Value and Sales Price)
8.1 Southeast Asia Peptide Hormone Sales and Value (2011-2016)
8.1.1 Southeast Asia Peptide Hormone Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Peptide Hormone Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Peptide Hormone Sales Price Trend (2011-2016)
8.2 Southeast Asia Peptide Hormone Sales and Market Share by Manufacturers
8.3 Southeast Asia Peptide Hormone Sales and Market Share by Type
8.4 Southeast Asia Peptide Hormone Sales and Market Share by Application
9 Global Peptide Hormone Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Peptide Hormone Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Pfizer Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Roche
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 125 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Roche Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Sanofi
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 144 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Sanofi Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Merck
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Oct Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Merck Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Eli Lilly
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Eli Lilly Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Novo Nordisk
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Novo Nordisk Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Boehringer Ingelheim
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma & Healthcare Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Boehringer Ingelheim Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Par Pharma
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Par Pharma Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 BioPartners
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 BioPartners Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Innovate
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Innovate Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Tarix Pharmaceuticals
10 Peptide Hormone Maufacturing Cost Analysis
10.1 Peptide Hormone Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Peptide Hormone
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Peptide Hormone Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Peptide Hormone Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Peptide Hormone Market Forecast (2016-2021)
14.1 Global Peptide Hormone Sales, Revenue Forecast (2016-2021)
14.2 Global Peptide Hormone Sales Forecast by Regions (2016-2021)
14.3 Global Peptide Hormone Sales Forecast by Type (2016-2021)
14.4 Global Peptide Hormone Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Peptide Hormone
Table Classification of Peptide Hormone
Figure Global Sales Market Share of Peptide Hormone by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Peptide Hormone
Figure Global Sales Market Share of Peptide Hormone by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Peptide Hormone Revenue and Growth Rate (2011-2021)
Figure China Peptide Hormone Revenue and Growth Rate (2011-2021)
Figure Europe Peptide Hormone Revenue and Growth Rate (2011-2021)
Figure Japan Peptide Hormone Revenue and Growth Rate (2011-2021)
Figure India Peptide Hormone Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Peptide Hormone Revenue and Growth Rate (2011-2021)
Figure Global Peptide Hormone Sales and Growth Rate (2011-2021)
Figure Global Peptide Hormone Revenue and Growth Rate (2011-2021)
Table Global Peptide Hormone Sales of Key Manufacturers (2011-2016)
Table Global Peptide Hormone Sales Share by Manufacturers (2011-2016)
Figure 2015 Peptide Hormone Sales Share by Manufacturers
Figure 2016 Peptide Hormone Sales Share by Manufacturers
Table Global Peptide Hormone Revenue by Manufacturers (2011-2016)
Table Global Peptide Hormone Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Peptide Hormone Revenue Share by Manufacturers
Table 2016 Global Peptide Hormone Revenue Share by Manufacturers
Table Global Peptide Hormone Sales and Market Share by Type (2011-2016)
Table Global Peptide Hormone Sales Share by Type (2011-2016)
Figure Sales Market Share of Peptide Hormone by Type (2011-2016)
Figure Global Peptide Hormone Sales Growth Rate by Type (2011-2016)
Table Global Peptide Hormone Revenue and Market Share by Type (2011-2016)
Table Global Peptide Hormone Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Peptide Hormone by Type (2011-2016)
Figure Global Peptide Hormone Revenue Growth Rate by Type (2011-2016)
Table Global Peptide Hormone Sales and Market Share by Regions (2011-2016)
Table Global Peptide Hormone Sales Share by Regions (2011-2016)
Figure Sales Market Share of Peptide Hormone by Regions (2011-2016)
Figure Global Peptide Hormone Sales Growth Rate by Regions (2011-2016)
Table Global Peptide Hormone Revenue and Market Share by Regions (2011-2016)
Table Global Peptide Hormone Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Peptide Hormone by Regions (2011-2016)
Figure Global Peptide Hormone Revenue Growth Rate by Regions (2011-2016)
Table Global Peptide Hormone Sales and Market Share by Application (2011-2016)
Table Global Peptide Hormone Sales Share by Application (2011-2016)
Figure Sales Market Share of Peptide Hormone by Application (2011-2016)
Figure Global Peptide Hormone Sales Growth Rate by Application (2011-2016)
Figure USA Peptide Hormone Sales and Growth Rate (2011-2016)
Figure USA Peptide Hormone Revenue and Growth Rate (2011-2016)
Figure USA Peptide Hormone Sales Price Trend (2011-2016)
Table USA Peptide Hormone Sales by Manufacturers (2011-2016)
Table USA Peptide Hormone Market Share by Manufacturers (2011-2016)
Table USA Peptide Hormone Sales by Type (2011-2016)
Table USA Peptide Hormone Market Share by Type (2011-2016)
Table USA Peptide Hormone Sales by Application (2011-2016)
Table USA Peptide Hormone Market Share by Application (2011-2016)
Figure China Peptide Hormone Sales and Growth Rate (2011-2016)
Figure China Peptide Hormone Revenue and Growth Rate (2011-2016)
Figure China Peptide Hormone Sales Price Trend (2011-2016)
Table China Peptide Hormone Sales by Manufacturers (2011-2016)
Table China Peptide Hormone Market Share by Manufacturers (2011-2016)
Table China Peptide Hormone Sales by Type (2011-2016)
Table China Peptide Hormone Market Share by Type (2011-2016)
Table China Peptide Hormone Sales by Application (2011-2016)
Table China Peptide Hormone Market Share by Application (2011-2016)
Figure Europe Peptide Hormone Sales and Growth Rate (2011-2016)
Figure Europe Peptide Hormone Revenue and Growth Rate (2011-2016)
Figure Europe Peptide Hormone Sales Price Trend (2011-2016)
Table Europe Peptide Hormone Sales by Manufacturers (2011-2016)
Table Europe Peptide Hormone Market Share by Manufacturers (2011-2016)
Table Europe Peptide Hormone Sales by Type (2011-2016)
Table Europe Peptide Hormone Market Share by Type (2011-2016)
Table Europe Peptide Hormone Sales by Application (2011-2016)
Table Europe Peptide Hormone Market Share by Application (2011-2016)
Figure Japan Peptide Hormone Sales and Growth Rate (2011-2016)
Figure Japan Peptide Hormone Revenue and Growth Rate (2011-2016)
Figure Japan Peptide Hormone Sales Price Trend (2011-2016)
Table Japan Peptide Hormone Sales by Manufacturers (2011-2016)
Table Japan Peptide Hormone Market Share by Manufacturers (2011-2016)
Table Japan Peptide Hormone Sales by Type (2011-2016)
Table Japan Peptide Hormone Market Share by Type (2011-2016)
Table Japan Peptide Hormone Sales by Application (2011-2016)
Table Japan Peptide Hormone Market Share by Application (2011-2016)
Figure India Peptide Hormone Sales and Growth Rate (2011-2016)
Figure India Peptide Hormone Revenue and Growth Rate (2011-2016)
Figure India Peptide Hormone Sales Price Trend (2011-2016)
Table India Peptide Hormone Sales by Manufacturers (2011-2016)
Table India Peptide Hormone Market Share by Manufacturers (2011-2016)
Table India Peptide Hormone Sales by Type (2011-2016)
Table India Peptide Hormone Market Share by Type (2011-2016)
Table India Peptide Hormone Sales by Application (2011-2016)
Table India Peptide Hormone Market Share by Application (2011-2016)
Figure Southeast Asia Peptide Hormone Sales and Growth Rate (2011-2016)
Figure Southeast Asia Peptide Hormone Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Peptide Hormone Sales Price Trend (2011-2016)
Table Southeast Asia Peptide Hormone Sales by Manufacturers (2011-2016)
Table Southeast Asia Peptide Hormone Market Share by Manufacturers (2011-2016)
Table Southeast Asia Peptide Hormone Sales by Type (2011-2016)
Table Southeast Asia Peptide Hormone Market Share by Type (2011-2016)
Table Southeast Asia Peptide Hormone Sales by Application (2011-2016)
Table Southeast Asia Peptide Hormone Market Share by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Peptide Hormone Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Peptide Hormone Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Peptide Hormone Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Peptide Hormone Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Peptide Hormone Global Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Peptide Hormone Global Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Peptide Hormone Global Market Share (2011-2016)
Table Par Pharma Basic Information List
Table Par Pharma Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Par Pharma Peptide Hormone Global Market Share (2011-2016)
Table BioPartners Basic Information List
Table BioPartners Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BioPartners Peptide Hormone Global Market Share (2011-2016)
Table Innovate Basic Information List
Table Innovate Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Innovate Peptide Hormone Global Market Share (2011-2016)
Table Tarix Pharmaceuticals Basic Information List
Table Tarix Pharmaceuticals Peptide Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Tarix Pharmaceuticals Peptide Hormone Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Hormone
Figure Manufacturing Process Analysis of Peptide Hormone
Figure Peptide Hormone Industrial Chain Analysis
Table Raw Materials Sources of Peptide Hormone Major Manufacturers in 2015
Table Major Buyers of Peptide Hormone
Table Distributors/Traders List
Figure Global Peptide Hormone Sales and Growth Rate Forecast (2016-2021)
Figure Global Peptide Hormone Revenue and Growth Rate Forecast (2016-2021)
Table Global Peptide Hormone Sales Forecast by Regions (2016-2021)
Table Global Peptide Hormone Sales Forecast by Type (2016-2021)
Table Global Peptide Hormone Sales Forecast by Application (2016-2021)
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 72
    C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2017, outlays comprehensive info......
  • C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 59
    C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - CXCR2 or Interleukin 8 receptor, beta is a chemokine receptor. It binds to IL8 with high affinity, and transduces the signal through a G-prot......
  • C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 54
    C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017, outlays comprehensive information on the C5a Anaphylato......
  • Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 53
    Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) receptors are G protein-coupled receptors that binds and is activated by prostaglandin D2. ......
  • Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 45
    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. ......
  • Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 74
    Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017 Summary Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) pipeline Target constitutes close to 17 molecules. Out of which approximately 17 molecules are developed by Companies. The lat......
  • Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 49
    Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. GLP2 prevent......
  • Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 55
    Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017 Summary According to the recently published report 'Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017'; Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. M......
  • Restenosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family hist......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs